|
$6,495.00
By: , Published: Apr-2013
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France, Ger.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France.....
|
|
|
$3,500.00
By: , Published: Apr-2013
GlobalData has released its medical devices report, “Peripheral Vascular Stents for the Lower Extremity - Current and Future Players”. The report is an essential source of information and analysis on the global Peripheral Vascular Stent (PVS) market. Through GlobalData’s analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as c.....
|
|
|
$6,495.00
By: , Published: Mar-2013
GlobalData has released its medical device report, “Cardiac Assist Devices - Global Device Forecasts and Market Analysis”. The report offers a comprehensive analysis of the global Cardiac Assist Device (CAD) Market, including development and sales in the Intra-Aortic Balloon Pump (IABP), Ventricular Assist Device (VAD), and Total Artificial Heart (TAH) global markets. Included within is an examination of the drivers, opportunities and barriers im.....
|
|
|
$4,450.00
By: , Published: Mar-2013
Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patient’s heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart Failure (CHF), where the chances of survival through oral medications alone become minimal. The scarcity of donor organs has led to the development of interim int.....
|
|
|
$4,450.00
By: , Published: Mar-2013
Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patient’s heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart Failure (CHF), where the chances of survival through oral medications alone become minimal. The scarcity of donor organs has led to the development of interim int.....
|
|
|
$4,450.00
By: , Published: Mar-2013
Cardiac Assist Devices (CAD) are mechanical pumps that work in conjunction with a patient’s heart to improve the pumping efficiency, increase the cardiac output and restore normal blood circulation. The devices are typically employed in patients suffering from end-stage Congestive Heart Failure (CHF), where the chances of survival through oral medications alone become minimal. The scarcity of donor organs has led to the development of interim int.....
|
|
|
$3,500.00
By: , Published: Mar-2013
While heart transplantation remains the gold standard and preferred treatment option for patients with advanced Congestive Heart Failure (CHF), the number of transplant candidates far exceeds the donor pool. This significant limitation has prompted considerable, continued interest in the development of Cardiac Assist Devices (CAD) that are capable of supporting patients with severe CHF, either until donor hearts become available or as an alternat.....
|
|
|
$6,495.00
By: , Published: Dec-2012
Coronary artery disease and peripheral artery disease are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable stents, which provide transient support to the vessel and degrade overtime, are viable alternatives to permanent drug-eluting and bare metal stent implants. In the report, bioabsorbable stents are defined as fully biodegradable stents that completely disappear over time. The emerging Bioabs.....
|
|
|
$4,450.00
By: , Published: Dec-2012
GlobalData has released its medical device report, Bioabsorbable Stents - EU Analysis and Market Forecasts. The report is a vital source of up-to-date information with in-depth analysis on the Bioabsorbable Stent (BAS) Market in France, Germany, Italy, Spain and the UK (EU). Provided within is a comprehensive breakdown of opportunities and inhibitors within the major EU BAS markets, highlighting testimonials from physicians from around the world .....
|
|
|
$4,450.00
By: , Published: Dec-2012
GlobalData has released its medical device report, Bioabsorbable Stents - US Analysis and Market Forecasts. The report is a vital source of up-to-date information with in-depth analysis on the Bioabsorbable Stent (BAS) Market in the US. Provided within is a comprehensive breakdown of opportunities and inhibitors within the US BAS market, highlighting testimonials from physicians from around the world utilizing this technique already. Currently, B.....
|
|
|
$3,500.00
By: , Published: Dec-2012
Bioabsorbable stents (BAS) offer a novel treatment solution for patients with coronary artery disease and peripheral artery disease. They represent the future of stents, as they address the unmet needs of the current stent market. As more long-term clinical data is available demonstrating its superior therapeutic benefits, adoption of bioabsorbable stents by the medical community will increase in the future. As coronary artery disease and periphe.....
|
|
|
$3,500.00
By: , Published: Nov-2012
GBI Research’s report, “Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth” provides key data, information and analysis on the medical devices market in China. The report provides a market landscape, competitive landscape and market trends information on ten medical devices markets: ophthalmic devices, In Vitro Diagnostics (IVD), diagnostic imaging,.....
|
|
|
$6,495.00
By: , Published: Nov-2012
For patients suffering from severe aortic valve disease or valve dysfunction, percutaneous Transcatheter Aortic Valve Replacement (TAVR) enables implantation of a prosthetic heart valve within the diseased native aortic valve without the need for open heart surgery or cardiopulmonary bypass; TAVR provides a new therapeutic option for elderly patients who are considered to have high surgical risk or contraindications to open heart surgery, in addi.....
|
|
|
$4,450.00
By: , Published: Nov-2012
GlobalData has released its medical device report, “Transcatheter Aortic Valve Replacement – EU Analysis and Market Forecasts. The report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in France, Germany, Italy, Spain and the UK (EU). Provided within is a comprehensive breakdown of opportunities and inhibitors within the major EU TAVR markets, h.....
|
|
|
$4,450.00
By: , Published: Nov-2012
GlobalData has released its medical device report, “Transcatheter Aortic Valve Replacement – US Analysis and Market Forecasts”. The report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in the US. Provided within is a comprehensive breakdown of opportunities and inhibitors within the US TAVR market, highlighting testimonials from top physicians .....
|
|
|
$3,500.00
By: , Published: Nov-2012
GlobalData has released its medical device report, “Transcatheter Aortic Valve Replacement – Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market. The report identifies and analyses the key companies shaping and driving the global Transcatheter Aortic Valve Replacement market. The report provides.....
|
|
|
$3,500.00
By: , Published: Oct-2012
GBI Research’s report, “Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers” provides key data, information and analysis for the global peripheral vascular devices market. It examines the market and competitive landscape and trends for the eight market segments: stent grafts, peripheral vascular stents, Percutaneous Transluminal Angioplasty (.....
|
|
|
$1,000.00
By: , Published: Oct-2012
GlobalData’s report, “Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis” provides key information, analysis and companies with their exhibited products at the HFSA 2012 Conference. The report provides the highlights of the meeting, presentations and key participants with description on their exhibited products.
This report is built using data and information sourced from proprietary databases, primary a.....
|
|
|
$2,500.00
By: , Published: Sep-2012
GlobalData’s new report, “Denmark Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others” provides key market data on the Denmark Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories Cardiac Assis.....
|
|
|
$2,500.00
By: , Published: Sep-2012
”Poland Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Poland Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Card.....
|
|
|
$2,500.00
By: , Published: Sep-2012
”Switzerland Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Switzerland Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Dev.....
|
|